APS Logo

Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer

ORAL · Invited

Presenters

  • Jessica Cunningham

    Fralin Biomedical Research Institute at Virginia Tech

Authors

  • Jessica Cunningham

    Fralin Biomedical Research Institute at Virginia Tech